About Chembio Diagnostics
Chembio Diagnostics develops, manufactures and commercialises point-of-care diagnostic tests based on their patented DPP (Dual Path Platform) technology. Products are used in community health settings, clinics and hospitals to diagnose HIV, syphilis, hepatitis B & C, Zika and other infectious diseases, particularly in resource-limited settings across Latin America, Africa and Southeast Asia.
📍 Location & Offices
📋 Request a Quote
Send your requirements directly to Chembio Diagnostics. Response typically within 48 hours.
Company Info
TypePublic
StockCEMI (NASDAQ)
Founded1985
Employees500
Revenue$130M
HQMedford, USA